Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UT Southwestern researchers find protein that both instigates, inhibits heart growth in mice

20.09.2002


Researchers at UT Southwestern Medical Center at Dallas have discovered a protein that regulates growth and development of the heart from its fetal stage to adulthood.


Dr. Eric Olson and a team of researchers have discovered a protein that continuously regulates heart development in mice from the embryonic stage to adulthood.



Findings published in today’s edition of Cell report that the protein, named Homeodomain-Only Protein (HOP) by the researchers, is active in controlling heart growth at various stages of development in mice. Dr. Eric Olson, chairman of molecular biology at UT Southwestern and the study’s principal investigator, said the team set out to find proteins unique to the heart and study their functions. After they identified HOP, they bred mice that were genetically unable to produce the protein, with dramatic results.

"We created knockout mice lacking the gene to produce this protein, and they fell into two classes – they either died as embryos because their hearts didn’t grow, or they survived to adulthood with too many cardiac muscle cells," said Olson, director of the Nancy B. and Jake L. Hamon Center for Basic Research in Cancer and the Nearburg Family Center for Basic Research in Pediatric Oncology.


"Understanding the mechanisms that regulate growth of heart cells has important implications for eventual therapies directed toward repairing the damaged heart," Olson said.

Observed problems during the fetal stages of the mutant mice included numerous ruptures of the ventricular walls, thin heart chamber layers and blood in the fibrous tissue surrounding the heart. After birth, there were elevations – as much as 19-fold – in the number of growing cardiac muscle cells in mutant compared to wild-type mice, and gene profiling showed that 179 genes had elevated expression and 90 genes had reduced expression.

The researchers believe that HOP works by controlling levels of serum response factor (SRF), a gene-activating protein, during heart development. SRF and three sibling proteins form a group called the MADS-box, and those proteins trigger genetic activity that produces a number of organs and systems. In the case of heart development, SRF controls the number and types of cells produced, and HOP controls the activity of SRF. Without HOP, SRF can’t properly balance heart-cell proliferation and differentiation, resulting in either an underdeveloped or overdeveloped heart.

"There has to be a finely tuned balance of proliferation and differentiation of cardiac cells for normal heart development," said Olson. "There’s a lot of interest in regulating the cardiac-cell cycle because the heart can’t repair itself; it can’t regenerate cells efficiently."

While Olson and his team believe the identification of HOP and its role in heart development is important, they also believe they’ve only uncovered a small fragment of the tableau.

"We need to figure out how to regulate HOP; obviously, other signals and proteins have to be involved to dictate that," Olson said. "But HOP is an important component of a mechanism that regulates heart growth."

San Diego-based Collateral Therapeutics Inc., a company working to develop genetic treatments for heart ailments, already has licensed the research in order to explore drug-development possibilities.

Wayne Carter | EurekAlert!
Further information:
http://www.swmed.edu/

More articles from Life Sciences:

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

nachricht The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

Decoding cement's shape promises greener concrete

08.12.2016 | Materials Sciences

Will Earth still exist 5 billion years from now?

08.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>